Acanthosis Nigricans: Clinical Trials

18 trials for Acanthosis Nigricans, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 6 unknown, 1 not yet recruiting. 7 Not applicable, 2 Phase 2, 2 Phase 3, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 5, Unknown 2
Phase 22Completed 2
Phase 32Completed 2
Phase 11Not yet recruiting 1
Phase 41Unknown 1

Follow Acanthosis Nigricans: new trials by email Literature Review of Acanthosis Nigricans trials Research Report on Acanthosis Nigricans

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Of Fractional Carbon Dioxide Laser Plus Topical Metformin In Treatment Of Acanthosis Nigricans
Topical metformin - Acanthosis Nigricans
Phase 1Not yet recruitingAl-Azhar University342026-08-102026-08-12
Evaluating the Safety and Efficacy of Topical Sirolimus 0.2% to Treat Acanthosis Nigricans
Sirolimus 0.2% - Acanthosis Nigricans
Phase 2CompletedNarrows Institute for Biomedical Research52025-03-012025-11-28
Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance
Chromium picolinate, Placebo matching Chromium Picolinate - Insulin Resistance, Acanthosis Nigricans
Not applicableCompletedUruk University902025-01-012026-02-23
Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms.
In-lab polysomnography, Continuous positive airway pressure, Home sleep study device - Obstructive Sleep Apnea, Vasovagal Syncope
UnknownJordan Collaborating Cardiology Group2002024-03-102024-09-19
The Efficacy Tretinoin Cream in the Treatment of Axillary Hyperpigmentation Associated With Acanthosis Nigricans
0.025% Tretinoin - Acanthosis Nigricans, Hyperpigmentation
Phase 3CompletedSrinakharinwirot University202024-02-012024-08-13
Systemic and Topical Metformin Versus Glycolic Acid Peel for the Treatment of Acanthosis Nigricans
systemic metformin, topical intervention, glycolic acid 70% peeling - Acanthosis Nigricans
Not applicableCompletedTanta University542023-06-032026-08-07
Sustainable-psycho-nutritional Intervention Program and Its Effects on Health Outcomes and the Environment
Sustainable diet promotion through behavioral change intervention - Gut Microbiota, Hyperglycemia
Not applicableUnknownUniversity of Guadalajara1122022-10-012023-11-29
Comparison Of Outcome Of Treatment OF Topical 15%TCA VS Topical 0.05% Tretinoin In Treatment Of Acanthosis Nigricans
Topical 15% Trichloroacetic acid - Acanthosis Nigricans
Not applicableCompletedJinnah Postgraduate Medical Centre802022-08-012023-08-23
Study of the Effect of Fractional co2 Laser Versus Q Switched:NdYAG Laser in the Treatment of Acanthosis Nigricans
co2 laser - Acanthosis Nigricans
Not applicableUnknownCairo University202021-05-302021-05-19
The Effect of Laparoscopic Sleeve Gastrectomy on Insulin Secretion Pattern in Morbidly Obese Patients With Acanthosis Nigricans
LSG - Morbid Obesity, Acanthosis Nigricans
UnknownShen Qu1382017-06-012022-09-07
Clinical Efficacy and Safety of a Laparoscopic Sleeve Gastrectomy in Obese Patients
Laparoscopic sleeve gastrectomy - Obesity
CompletedShanghai 10th People's Hospital3002017-01-012022-09-14
Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity
Metformin, Placebo - Acanthosis Nigricans
Phase 4UnknownJuan Pablo Castanedo-Cazares302015-06-012015-05-08
Effect of Melatonin on Body Composition, Glucose Metabolism and Lipid Metabolism
melatonin - Acanthosis Nigricans, Obesity
Not applicableCompletedShanghai 10th People's Hospital162014-05-012015-11-16
Children's Healthy Living Community Randomized Trial
CHL program, Delayed Optimized CHL program - Obesity, Acanthosis Nigricans
Not applicableCompletedUniversity of Hawaii98402012-11-012024-03-04
Adjunctive Metformin Therapy in Double Diabetes
Metformin, Placebo - Diabetes Mellitus
Phase 3CompletedUniversity of Massachusetts, Worcester282011-02-012016-03-04
Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia
Metformin, Dietary Modification - Acanthosis Nigricans, Hyperinsulinemia
CompletedHenry Ford Health System92009-02-012012-09-06
Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
leuprolide acetate, spironolactone - Acanthosis Nigricans, Polycystic Ovary Syndrome
Phase 2CompletedNational Center for Research Resources (NCRR)1989-07-012005-06-24
Prevalence of Carbohydrate Intolerance in Lean and Obese Children
Obesity, Glucose Intolerance
UnknownNational Center for Research Resources (NCRR)2005-06-24

Narrower conditions

Obesity (6)  ·  Diabetes Mellitus (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Hyperinsulinism (2)  ·  Insulin Resistance (2)  ·  Motor Activity (2)  ·  Polycystic Ovary Syndrome (2)  ·  Diabetes Mellitus, Type 1 (1)  ·  Endocrine System Diseases (1)  ·  Feeding Behavior (1)  ·  Glucose Intolerance (1)  ·  Hypercholesterolemia (1)  ·  Hyperglycemia (1)  ·  Hyperpigmentation (1)

Broader conditions

Melanosis (18)  ·  Pigmentation Disorders (18)  ·  Skin and Connective Tissue Diseases (18)  ·  Hyperpigmentation (17)  ·  Skin Diseases (17)  ·  Nutritional and Metabolic Diseases (10)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Signs and Symptoms (8)  ·  Body Weight (7)  ·  Glucose Metabolism Disorders (7)  ·  Metabolic Diseases (7)  ·  Nutrition Disorders (7)  ·  Overnutrition (7)  ·  Overweight (7)  ·  Behavior (3)

Interventions

Metformin (4)  ·  Tretinoin (2)  ·  Continuous Positive Airway Pressure (1)  ·  Diet Therapy (1)  ·  Lasers, Gas (1)  ·  Leuprolide (1)  ·  Melatonin (1)  ·  Methods (1)  ·  Polysomnography (1)  ·  Spironolactone (1)  ·  Tooth Exfoliation (1)  ·  Trichloroacetic Acid (1)  ·  glycolic acid (1)  ·  picolinic acid (1)

Sponsors

National Center for Research Resources (NCRR) (2)  ·  Shanghai 10th People's Hospital (2)  ·  Al-Azhar University (1)  ·  Cairo University (1)  ·  Henry Ford Health System (1)  ·  Jinnah Postgraduate Medical Centre (1)  ·  Jordan Collaborating Cardiology Group (1)  ·  Juan Pablo Castanedo-Cazares (1)  ·  Narrows Institute for Biomedical Research (1)  ·  Shen Qu (1)  ·  Srinakharinwirot University (1)  ·  Tanta University (1)  ·  University of Guadalajara (1)  ·  University of Hawaii (1)  ·  University of Massachusetts, Worcester (1)

Countries

United States (5)  ·  China (2)  ·  Mexico (2)  ·  Egypt (1)  ·  Iraq (1)  ·  Jordan (1)  ·  Pakistan (1)  ·  Thailand (1)

Top investigators

Arucha Treesirichod (1)  ·  Benjamin U Nwosu, MD (1)  ·  Bertha Torres-Alvarez, MD (1)  ·  Fatima E Housni, PhD (1)  ·  Fazia Inam, FCPS (1)  ·  Francisco Goldaracena-Orozco, MD (1)  ·  Ghasak Kais Abdulhussain, BSc, MSc, PhD (Pharmacology) (1)  ·  Iltefat Hamzavi, M.D. (1)  ·  Jared Jagdeo, MD MS (1)  ·  Juan P Castanedo-Cazares, MD (1)  ·  Karen E. Elkind-Hirsch (1)  ·  Nazia Jabeen, FCPS (1)  ·  Parisa Sanawar, FCPS (1)  ·  Rachel Novotny, PhD (1)  ·  Rand M Zaqqa (1)

Results publications

PMID 26367281, PMID 29706998, PMID 30586845, PMID 30646266, PMID 31116404, PMID 31421157, PMID 33234187, PMID 35235641, PMID 35399676, PMID 35666503, PMID 36469736, PMID 39511506, PMID 39989394, PMID 41796940, PMID 42029999

NIH funding

2018 (1), M01RR006022 (1)